Partial Seizures
📧 Sign up to get email alerts when something new happens for Partial Seizures.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-03-18FDA Approved: VIGABATRIN — Supplemental Application (Dr. Reddys Laboratories Inc.,)
FDA approved a supplemental application for Vigabatrin filed by Dr. Reddys Laboratories Inc.
-
FDA approval · 2026-03-18FDA Approved: VIGABATRIN — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for Vigabatrin submitted by Edenbridge Pharmaceuticals LLC, authorizing the marketing of the generic…
-
FDA approval · 2026-03-18FDA Approved: VIGABATRIN — Supplemental Application (Hikma Pharmaceuticals USA Inc)
The FDA approved a supplemental application for Vigabatrin from Hikma Pharmaceuticals USA Inc., updating the drug's labeling.
-
FDA approval · 2026-03-18FDA Approved: VIGABATRIN — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for Vigabatrin from Par Health USA, LLC under the ANDA (ANDA208218). This action represents added re…
-
FDA approval · 2026-03-18FDA Approved: VIGABATRIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Vigabatrin from Ascend Laboratories, LLC (ANDA 213375).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-09-18EMA Authorised: Zonegran (zonisamide) — Amdipharm Limited
The European Medicines Agency authorised Zonegran (zonisamide) for partial seizures; the marketing authorisation holder is Amdipharm Limited…
-
FDA approval · 2025-09-16FDA Approved: OXCARBAZEPINE — Supplemental Application (EPIC PHARMA, LLC)
FDA approved a supplemental application for oxcarbazepine submitted by Epic Pharma, LLC, authorizing a generic formulation under ANDA 215332…
-
FDA approval · 2025-08-15FDA Approved: OXCARBAZEPINE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
FDA approved a supplemental application for Oxcarbazepine by Breckenridge Pharmaceutical, Inc.
-
FDA approval · 2025-07-11FDA Approved: OXCARBAZEPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic oxcarbazepine tablet from Macleods Pharmaceuticals Limited under an Original Application (ANDA).
-
FDA approval · 2024-11-21FDA Approved: OXCARBAZEPINE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for oxcarbazepine filed by Ajanta Pharma USA Inc., approving changes related to the marketed product…
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN — Supplemental Application (Novadoz Pharmaceuticals LLC)
FDA approved a supplemental application for Vigabatrin by Novadoz Pharmaceuticals LLC. This action represents regulatory approval of an upda…
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN — Supplemental Application (Dr. Reddys Laboratories Inc.,)
FDA approved a supplemental application for Vigabatrin from Dr. Reddy's Laboratories Inc. (ANDA 211481).
-
FDA approval · 2024-09-12FDA Approved: VIGADRONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for Vigadrone (vigabatrin) from Upsher-Smith Laboratories, confirming an approved supplement to …
-
FDA approval · 2024-03-01FDA Approved: OXCARBAZEPINE — Original Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s oxcarbazepine as an Original Application (ANDA) generic. The drug is indicated for the treatment of partia…
-
FDA approval · 2024-02-22FDA Approved: OXCARBAZEPINE — Original Application (Ajanta Pharma USA Inc.)
The FDA approved Ajanta Pharma USA Inc.'s generic oxcarbazepine through an original application. It is indicated for the treatment of partia…
-
FDA approval · 2023-05-12FDA Approved: GABAPENTIN — Original Application (Laurus Labs Limited)
FDA approved Laurus Labs' generic Gabapentin original application. The approval covers its use for partial seizures and postherpetic neuralg…
-
FDA approval · 2023-04-28FDA Approved: VIGABATRIN — Original Application (Carnegie Pharmaceuticals LLC)
FDA approved the original application for a generic vigabatrin (VIGABATRIN) by Carnegie Pharmaceuticals LLC. Vigabatrin is used to treat cer…
-
FDA approval · 2023-03-28FDA Approved: GABAPENTIN — Original Application (Granules Pharmaceuticals Inc.)
FDA approved an original application for a generic gabapentin product from Granules Pharmaceuticals Inc.
-
FDA approval · 2023-03-01FDA Approved: OXCARBAZEPINE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for oxcarbazepine filed by Amneal Pharmaceuticals LLC.
-
FDA approval · 2022-10-12FDA Approved: VIGABATRIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for Vigabatrin by Amneal Pharmaceuticals NY LLC under ANDA210155, updating its regulatory status.
-
FDA approval · 2022-10-12FDA Approved: VIGABATRIN — Supplemental Application (Hikma Pharmaceuticals USA Inc)
FDA approved a supplemental application for Vigabatrin submitted by Hikma Pharmaceuticals USA Inc, representing an additional regulatory act…
-
FDA approval · 2022-08-30FDA Approved: OXCARBAZEPINE — Original Application (Advagen Pharma Ltd)
FDA approves the original application for oxcarbazepine from Advagen Pharma Ltd, granting approval for a generic version of the antiseizure …
-
FDA approval · 2021-11-16FDA Approved: TIAGABINE HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original ANDA for tiagabine hydrochloride from Novadoz Pharmaceuticals LLC, granting a generic version for the treatment of…
-
FDA approval · 2021-09-29FDA Approved: VIGABATRIN — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for Vigabatrin from Aurobindo Pharma Limited, enabling generic availability of the drug.
-
FDA approval · 2021-05-10FDA Approved: GABAPENTIN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic gabapentin under an Original Application (ANDA 214956); the product is indicated for partial se…